Clinical Trials Browser

Pancreatic cancer, adult, Carcinoma, Non-Small-Cell Lung, Glioblastoma, Carcinoma, Hepatocellular, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT04566029 2025-12-10

AMI

Completed

40 enrolled

Genitourinary

Carcinoma, Transitional Cell

NCT03284684 2025-12-01

Periop ctDNA

Completed

30 enrolled

BreastGastrointestinalGenitourinary

Breast Neoplasms, Colonic Neoplasms, Prostatic Neoplasms

NCT03409016 2025-09-05

Biomarkers of Immune-Related Toxicity

Active not recruiting

69 enrolled

Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT06979921 2025-08-14

PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale BREAST Cancers, PERCEIVE-BREAST

Active not recruiting

496 enrolled

Tumor-Agnostic

Neoplasms

NCT04053439 2025-07-08

Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications

Recruiting

188 enrolled

Lymphoid

Lymphoma

NCT04541212 2025-06-15

CarChem

Active not recruiting

169 enrolled

BreastLymphoidOther hematologic neoplasm

Breast Neoplasms, Leukemia, Lymphoma

NCT06967532 2025-05-13

TTV in NSCLC

Recruiting

90 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

Clinical Trials

RT4

Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib

EARDIS

Long-Term Follow-Up of Recipient of Gene Transfer Research

CCANED-CIPHER

AMI

Periop ctDNA

Biomarkers of Immune-Related Toxicity

PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale BREAST Cancers, PERCEIVE-BREAST

Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications

CarChem

TTV in NSCLC